South African stocks were a mixed bag with a weaker bias at noon on Thursday, but brewer SABMiller climbed on above-forecasts year end earnings. At noon, the all-share index was down 0,16%. Resources fell 0,67%, the gold mining index was off 1,62% but the platinum mining index added 0,15%.
South African stocks remained weak at midday on Tuesday with miners the worst causalities on easing metal prices, while falling overseas markets added to selling pressures. At 12.09pm, the JSE's broader all-share index was down 0,86%, weighed by a 2,88% drop in platinum miners.
South African stocks were mixed in a thin-volume session by noon on Friday, with MTN in focus on vague newspaper reports that an Indian firm might launch a takeover bid for the local mobile telecoms firm, traders said. By midday the JSE's broader all-share index was down 0,14%. Resources fell 1,27%.
World markets were dampened by negative earnings reports from the United States on Monday, causing the JSE to pull back sharply. By midday, the JSE's broader all-share index had fallen 1,48%. The banking index pulled back 2,51% and financials retreated 1,41%.
South African stocks were slightly lower at noon on Tuesday, pressured by miners on faltering metal prices, but improved sentiment in overseas markets restricted losses, traders said. At noon, the JSE's broader all-share index had given up 0,19% at 30 056,80.
The JSE held on to gains at midday on Tuesday as investors chased after bargains following Monday's sharp losses amid strong metal prices and firmer overseas markets. By 11.59am, the broader all-share index had added 0,82% to 27 860,790 thanks to a 3,27% gain in the platinum-mining index.
The JSE remained firm at noon on Tuesday, spurred by Wall Street's overnight rebound and firmer European markets as risk aversion eased. Miners lifted the main index, buoyed by a recovery in commodities prices as metals investors chased after bargains following Monday's sharp losses, while a slight weakness in the dollar added to the upbeat mood in the metals complex.
Rhulani Nhlaniki is Pfizer’s cluster lead for sub-Saharan Africa. As Pfizer starts phase III of the clinical trial of their Covid-19 vaccine candidate, he tells Malaikah Bophela that if it is successful, the company will ensure the vaccine will be available to everyone who needs it